Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma

JOURNAL ARTICLE published 1 October 2008 in Journal of Clinical Oncology

Authors: Kai Fu | Dennis D. Weisenburger | William W.L. Choi | Kyle D. Perry | Lynette M. Smith | Xinlan Shi | Christine P. Hans | Timothy C. Greiner | Philip J. Bierman | R. Gregory Bociek | James O. Armitage | Wing C. Chan | Julie M. Vose